[HTML] sciencedirect.com

[HTML][HTML] PAK-dependent regulation of actin dynamics in breast cancer cells

M Best, ME Gale, CM Wells - The international journal of biochemistry & …, 2022 - Elsevier
Abstract Metastatic Breast Cancer has a poor 25% survival rate and currently there are no
clinical therapeutics which target metastasis.'Migrastatics' are a new drug class which target …
被引用次数：6 相关文章
[HTML] nih.gov

[HTML][HTML] PAK-dependent regulation of actin dynamics in breast cancer cells

M Best, ME Gale, CM Wells - The International Journal of …, 2022 - ncbi.nlm.nih.gov
Abstract Metastatic Breast Cancer has a poor 25% survival rate and currently there are no
clinical therapeutics which target metastasis.'Migrastatics' are a new drug class which target …
[PDF] kcl.ac.uk

[PDF][PDF] PAK-dependent regulation of actin dynamics in breast cancer cells

M Best, ME Gale, CM Wells - International Journal of Biochemistry …, 2022 - kclpure.kcl.ac.uk
ABSTRACT Metastatic Breast Cancer has a poor 25% survival rate and currently there are
no clinical therapeutics which target metastasis.'Migrastatics' are a new drug class which …

PAK-dependent regulation of actin dynamics in breast cancer cells

M Best, ME Gale, CM Wells - The international journal of …, 2022 - pubmed.ncbi.nlm.nih.gov
Metastatic Breast Cancer has a poor 25% survival rate and currently there are no clinical
therapeutics which target metastasis.'Migrastatics' are a new drug class which target …

PAK-dependent regulation of actin dynamics in breast cancer cells.

M Best, ME Gale, CM Wells - … Journal of Biochemistry & Cell Biology, 2022 - europepmc.org
Abstract Metastatic Breast Cancer has a poor 25% survival rate and currently there are no
clinical therapeutics which target metastasis.'Migrastatics' are a new drug class which target …

PAK-dependent regulation of actin dynamics in breast cancer cells

M Best, ME Gale, CM Wells - International Journal of Biochemistry …, 2022 - kclpure.kcl.ac.uk
Abstract Metastatic Breast Cancer has a poor 25% survival rate and currently there are no
clinical therapeutics which target metastasis.'Migrastatics' are a new drug class which target …

[引用][C] PAK-dependent regulation of actin dynamics in breast cancer cells

M Best, ME Gale, CM Wells - 2022